FATE
FATE THERAPEUTICS INC
Key Financials
Net Income
$-136315000
↑ 26.8%
Operating Income
$-147704000
↑ 29.8%
Total Assets
$318.9M
↓ 27.6%
EPS (Diluted)
$-1.15
↑ 29.9%
Shareholders' Equity
$207.2M
↓ 35.0%
Revenue
$6.6M
↓ 51.2%
Cash & Equivalents
$46.6M
↑ 29.3%
Long-term Debt
$18.5M
↓ 4.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 10-K | 2/26/2026 | View on SEC |
| 8-K | 2/26/2026 | View on SEC |
| 4 | 1/16/2026 | View on SEC |
| 4 | 1/16/2026 | View on SEC |
| 4 | 1/16/2026 | View on SEC |
| 4 | 1/12/2026 | View on SEC |
| 4 | 1/12/2026 | View on SEC |
| 144 | 1/9/2026 | View on SEC |
| 144 | 1/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FATE |
| Company Name | FATE THERAPEUTICS INC |
| CIK | 1434316 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 858.875.1803 |